VivoSim Labs, Inc. Common Stock reported Q4 2025 revenue of $26.0K (+8.3% YoY), missed analyst consensus of $50.0K by $24.0K. Diluted EPS came in at $-1.03 (+55.0% YoY), beat the $-2.40 consensus by $1.37.
Trailing eight quarters through Q4 2025
Common questions about VivoSim Labs, Inc. Common Stock's Q4 2025 earnings report.
VivoSim Labs, Inc. Common Stock (VIVS) reported Q4 2025 earnings on February 11, 2026 before market open.
VivoSim Labs, Inc. Common Stock reported revenue of $26.0K and diluted EPS of $-1.03 for Q4 2025.
Revenue missed the consensus estimate of $50.0K by $24.0K. EPS beat the consensus estimate of $-2.40 by $1.37.
Compared to the same quarter a year prior, revenue grew 8.3% from $24.0K a year earlier and diluted EPS grew 55.0% from $-2.29.
You can read the 10-Q periodic report (0001193125-26-046520) directly on SEC EDGAR. The filing index links above go to sec.gov.